A carregar...

Real-World Economic Impact of OnabotulinumtoxinA in Patients With Chronic Migraine

OBJECTIVE: To determine whether the utilization of healthcare resources is reduced after chronic migraine patients are treated for 6 months with onabotulinumtoxinA. BACKGROUND: OnabotulinumtoxinA is indicated for headache prophylaxis in patients with chronic migraine, but its effect on healthcare re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Headache
Main Authors: Rothrock, John F, Bloudek, Lisa M, Houle, Timothy T, Andress-Rothrock, Diane, Varon, Sepideh F
Formato: Artigo
Idioma:Inglês
Publicado em: BlackWell Publishing Ltd 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4282490/
https://ncbi.nlm.nih.gov/pubmed/25298117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/head.12456
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!